Conférences  >  Médecine & Soins de Santé  >  Immunologie et Allergie  >  Virtuel (en ligne)

Sélecionner un pays
1
EUSTM-2024 — 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care
06 sep 2024 - 08 sep 2024 • Online Congress, Virtuel (en ligne)
Organisateur:
European Society for Translational Medicine
Résumé:
The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2024) held in virtual format during 6-8 September, 2024. The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care. EUSTM-2024 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.
Contact:
Tél.: [+43 1 8923 562];     Email.: immuno-2024@eutranslationalmedicine.org
Sujets:
solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, vaccines biological research, diagnostics, biomarkers, clinical care, Immunology, MIcrobiology, life sciences, Molecular Biology, Cancer, Blood Cancers, Breast cancer, Lungs Cancer, Ovarian cancer, GIT cancer, Brain cancer, Genitourinary cancer, prostate cancer, bladder cancer,
Identifiant de l'évènement:
1619591
2
EACR Systemic Consequences of Cancer: Cancer as a Whole-body Disease
25 fév 2025 - 26 fév 2025 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
This meeting will delve into the profound consequences cancer can have on the body’s usual functions, and the underlying mechanisms behind these systemic effects. The ultimate goal is to explore how we might manipulate these mechanisms to develop more effective cancer treatments and improve the quality of life of patients with advanced cancer. We’ll be covering a wide range of topics including alterations in peripheral tissue function and the metabolic and inflammatory changes they induce, immune system performance, and cancer cachexia. This conference will be relevant for anyone with an interest in cancer biology, inter-organ communication, the role of cytokines, chemokines, and hormones in cancer, as well as cancer-induced changes in behaviour and metabolism.

Join us online on 25 and 26 February to learn more about this fascinating topic! Submit your abstract before 13 January and register before 03 February to secure your place.

Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, oncology, cancer biology, immunology, cancer cachexia, inter-organ communication, liver function, muscle function, adipose tissue function, tissue function, metabolic changes, inflammatory changes, tumour metastasis, novel therapeutic interventions, cytokines, chemokines, hormones, cancer metabolism
Identifiant de l'évènement:
1620088
Sujets apparentés:


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Y'a pas de suivi | Y'a pas de pop-ups | Y'a pas d'animations
Dernière mise à jour: 26 mai 2024